Literature DB >> 23784005

Passive fructose transporters in disease: a molecular overview of their structural specificity.

D Tyler McQuade1, Matthew B Plutschack, Peter H Seeberger.   

Abstract

The SLC2 family of facilitative Glucose transporters (Gluts) contains 14 isoforms divided into three classes based on amino acid sequence. While the majority of these proteins transport glucose, a subset can transport fructose. Recently, fructose and the Gluts responsible for fructose uptake have received increased interest due to the correlation between high fructose consumption and early onset of metabolic syndrome. In addition, the up-regulation of Gluts in certain cancers has made possible the development of a number of fructose probes for imaging cancer. Although structure activity data has defined some aspects of fructose-specific uptake, a far more detailed clarification of the variables governing the onset and progression of fructose-correlated diseases is still needed. Here, we summarize what is known about molecular structure and fructose uptake as it relates to the correlation of fructose and disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784005     DOI: 10.1039/c3ob40805a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

1.  Towards Selective Binding to the GLUT5 Transporter: Synthesis, Molecular Dynamics and In Vitro Evaluation of Novel C-3-Modified 2,5-Anhydro-D-mannitol Analogs.

Authors:  Natasha Rana; Marwa A Aziz; Ahmed K Oraby; Melinda Wuest; Jennifer Dufour; Khaled A M Abouzid; Frank Wuest; F G West
Journal:  Pharmaceutics       Date:  2022-04-10       Impact factor: 6.525

Review 2.  Avian and Mammalian Facilitative Glucose Transporters.

Authors:  Mary Shannon Byers; Christianna Howard; Xiaofei Wang
Journal:  Microarrays (Basel)       Date:  2017-04-05

Review 3.  Importance of GLUT Transporters in Disease Diagnosis and Treatment.

Authors:  Abdelrahman Ismail; Marina Tanasova
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

4.  Targeting of GLUT5 for Transporter-Mediated Drug-Delivery Is Contingent upon Substrate Hydrophilicity.

Authors:  Nazanin Nahrjou; Avik Ghosh; Marina Tanasova
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 6.208

5.  Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation.

Authors:  Alayna M George Thompson; Oleg Ursu; Petr Babkin; Cristina V Iancu; Alex Whang; Tudor I Oprea; Jun-yong Choe
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

6.  Metabolism-Driven High-Throughput Cancer Identification with GLUT5-Specific Molecular Probes.

Authors:  Srinivas Kannan; Vagarshak V Begoyan; Joseph R Fedie; Shuai Xia; Łukasz J Weseliński; Marina Tanasova; Smitha Rao
Journal:  Biosensors (Basel)       Date:  2018-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.